Neurogenetics, Part II, Volume 148, the latest release in the Handbook of Clinical Neurology, provides the latest information on the genetic methodologies that are having a significant impact on the study of neurological and psychiatric disorders. Using genetic science, researchers have identified over 200 genes that cause or contribute to neurological disorders. Still an evolving field of study, defining the relationship between genes and neurological and psychiatric disorders is expected to dramatically grow in scope. Part II builds on the foundation of Part I, expanding the coverage to…mehr
Neurogenetics, Part II, Volume 148, the latest release in the Handbook of Clinical Neurology, provides the latest information on the genetic methodologies that are having a significant impact on the study of neurological and psychiatric disorders. Using genetic science, researchers have identified over 200 genes that cause or contribute to neurological disorders. Still an evolving field of study, defining the relationship between genes and neurological and psychiatric disorders is expected to dramatically grow in scope. Part II builds on the foundation of Part I, expanding the coverage to dementias, paroxysmal disorders, neuromuscular disorders, white matter and demyelination diseases, cerebrovascular diseases, adult psychiatric disorders and cancer and phacomatoses. Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Dr. Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry at UCLA. In his capacity as Senior Associate Dean and Associate Vice Chancellor of Precision Health, he leads the Institute for Precision Health at UCLA. His laboratory has pioneered the application of systems biology methods in neurologic and psychiatric disease, describing multiple disease-causing genes and disease mechanisms in the book "Neurodevelopmental and Neurodegenerative Diseases.? Dr. Geschwind has put considerable effort into fostering large-scale collaborative patient resources for genetic research and data sharing in autism research. He has served on numerous scientific advisory boards, including the Faculty of 1000 Medicine, the Executive Committee of the American Neurological Association, the Scientific Advisory Board for the Allen Institute for Brain Science, the NIMH Advisory Council and the NIH Council of Councils. He has published over 400 pape
rs and serves on the editorial boards of Cell, Neuron and Science. He has received several awards for his laboratory's work and leadership including the Ruane Prize from the Brain and Behavior Foundation in 2013 and the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association (ANA) in 2004. He is an elected Member of the American Association of Physicians and the National Academy of Medicine.
Inhaltsangabe
Section V. Dementias 26. The genetic landscape of Alzheimer disease 27. Frontotemporal dementia 28. The genetics of dementia with Lewy bodies 29. Prion disease
Section VI. Paroxysmal Disorders 30. Genetics of epilepsy 31. Genetics of migraine 32. Periodic paralysis 33. Episodic ataxias 34. Disorders of sleep and circadian rhythms
Section VII. Neuromuscular Disorders 35. Facioscapulohumeral muscular dystrophy 36. The genetics of congenital myopathies 37. Genetic basis and phenotypic features of congenital myasthenic syndromes 38. Spinal muscular atrophy 39. Emerging understanding of the genotype: Phenotype relationship in amyotrophic lateral sclerosis 40. Spinal and bulbar muscular atrophy 41. Hereditary spastic paraplegia 42. Neuropathy
Section VIII. Diseases of White Matter and Demyelination 43. The spectrum of adult-onset heritable white matter disorders 44. Alexander disease 45. Neurogenetics of Pelizaeus-Merzbacher disease 46. Multiple sclerosis
Section IX. Cerebrovascular Diseases 47. CADASIL
Section X. Major Adult Psychiatric Disorders 48. Neuroepigenetics and addiction 49. Genetic susceptibility in obsessive-compulsive disorder
Section XI. Cancer and Phakomatoses 50. Brain cancer genomics and epigenomics 51. Neurofibromatosis type 1 52. Tuberous sclerosis complex 53. Von Hippel-Lindau disease and Sturge-Weber syndrome
Section V. Dementias 26. The genetic landscape of Alzheimer disease 27. Frontotemporal dementia 28. The genetics of dementia with Lewy bodies 29. Prion disease
Section VI. Paroxysmal Disorders 30. Genetics of epilepsy 31. Genetics of migraine 32. Periodic paralysis 33. Episodic ataxias 34. Disorders of sleep and circadian rhythms
Section VII. Neuromuscular Disorders 35. Facioscapulohumeral muscular dystrophy 36. The genetics of congenital myopathies 37. Genetic basis and phenotypic features of congenital myasthenic syndromes 38. Spinal muscular atrophy 39. Emerging understanding of the genotype: Phenotype relationship in amyotrophic lateral sclerosis 40. Spinal and bulbar muscular atrophy 41. Hereditary spastic paraplegia 42. Neuropathy
Section VIII. Diseases of White Matter and Demyelination 43. The spectrum of adult-onset heritable white matter disorders 44. Alexander disease 45. Neurogenetics of Pelizaeus-Merzbacher disease 46. Multiple sclerosis
Section IX. Cerebrovascular Diseases 47. CADASIL
Section X. Major Adult Psychiatric Disorders 48. Neuroepigenetics and addiction 49. Genetic susceptibility in obsessive-compulsive disorder
Section XI. Cancer and Phakomatoses 50. Brain cancer genomics and epigenomics 51. Neurofibromatosis type 1 52. Tuberous sclerosis complex 53. Von Hippel-Lindau disease and Sturge-Weber syndrome
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
